Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Meilan Han (Ann Arbor, United States of America). Macrolides for COPD: factors associated with treatment success. International Congress 2015 – Individualised risk reduction strategies for patients with COPD

Member's Comments

No comment yet.

Related content which might interest you: Key factors associated with readmission in COPD patients Source: Annual Congress 2013 –COPD biomarkers Year: 2013 NIMV in the treatment of COPD exacerbations: predictors of success Source: Eur Respir J 2004; 24: Suppl. 48, 312s Year: 2004 Compliance to asthma treatment and its risk factors Source: Eur Respir J 2005; 26: Suppl. 49, 508s Year: 2005 Factors associated with therapeutic compliance in COPD Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease Year: 2017 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Efficacy of PO moxifloxacin in the treatment of AECOPD in patients with risk factors for poor outcomes Source: Annual Congress 2009 - COPD case-finding and management in primary care Year: 2009 Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Adherence rate to inhaled therapies and factors affecting adherence in elderly with chronic obstructive lung diseases Source: International Congress 2018 – Primary care management of respiratory conditions Year: 2018 Factors influencing medication adherence amongst difficult-to-treat asthma patients Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Factors associated with exacerbations in US patients with COPD Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Factors affecting adherence to prescribed asthma treatment Source: Eur Respir J 2002; 20: Suppl. 38, 80s Year: 2002 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations? Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics Year: 2017 The adherence to inhaled drugs in COPD patients: Effect on survival Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Risk factors for asthma exacerbations: is severity a predictor? Source: Annual Congress 2003 - Burden of asthma Year: 2003 Macrolides in the prevention of COPD exacerbations Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Exacerbations in severe persistent asthma - impact of risk factors control Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005 Noncompliance factors in Russian asthma and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 274s Year: 2005 Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008